_
 

Mar 20, 2008
Cenix BioScience and CellCentric Sign Framework Research Agreement for RNAi-Based Target Validation ...
Mar 19, 2008
Cenix BioScience Signs Framework Research Agreement with AstraZeneca for RNAi-Based Drug Discovery ...


May 17 - 21, 2008, Budapest
ISAC - XXIV Intl. Congress ...
Jun 8 - 11, 2008, San Francisco, CA
Beyond Genome 2008 - RNA Interference ...

 
 
Cenix BioScience is a specialist in advanced, cell-based applications of RNA interference (RNAi), a breakthrough gene silencing technology for the discovery and functional characterization of novel therapeutic targets and drug candidates.

With over 8 years of experience focused on combining genome-driven, high throughput RNAi with high content phenotypic analyses in cultured human and rodent cells, we offer these capabilities through fully-customizable Premium Research Services to industry and academic clients.

Our mission is to accelerate and improve the quality of therapeutic drug discovery and development in a broad range of disease areas.
© Cenix BioScience GmbH 2008. All rights reserved.